EDIT:NASDAQ
Editas Medicine Inc
2,17 USD
arrow_upward
+1,40%(+0,030) 1D
13. stu, 16:00:01 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Otvori
2,14 USD
Najviša
2,21 USD
Najniža
2,01 USD
Trž. kap.
334,92 mil.
Prosj. kol.
2,42 mil.
Količina
2,79 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Otvori
2,14 USD
Najviša
2,21 USD
Najniža
2,01 USD
Trž. kap.
334,92 mil.
Prosj. kol.
2,42 mil.
Količina
2,79 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
The Motley Fool
·
prije 1 sat
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
TradingKey
·
prije 10 sati
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
TradingView
·
prije 17 sati
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
prije 1 sat
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com